
Rand Paul’s wife bought stock in COVID treatment firm in February 2020
NY Post
Sen. Rand Paul revealed Wednesday in a disclosure that was more than a year overdue that his wife in February 2020 bought up to $15,000 worth of shares in Gilead, a biotech company that brought to market the first drug designed to treat COVID-19.
Paul’s mandatory filing with the Senate shows that his wife purchased between $1,000 and $15,000 worth of Gilead stock on Feb. 26, 2020. Gilead’s antiviral drug remdesivir became the first COVID-19 specific treatment to win an emergency use authorization from the Food and Drug Administration less that three months after the purchase in May 2020.More Related News

Gas prices reach highest level since October 2023 as oil holds above $100 per barrel; US stocks jump
Brent crude oil held above $100 per barrel on Monday, pushing national average gasoline prices to their highest level since October 2023 as President Trump urged allies to help protect oil tankers from Iranian attacks in the key Strait of Hormuz.












